Cardiogramme Echographie Salle d'opération Salle d'opération
Logo   Accueil | Table des matières | Téléchargements | Liens |   Mentions légales   | Contact |Abréviations
Logo  

Bibliographie

Lectures conseillées

JANVIER G, LEHOT JJ, éditeurs. Circulation extracorporelle: principes et pratique, 2ème édition. Paris: Arnette Groupe Liaison SA, 2004
HOGUE CW, PALIN CA, ARROWSMITH JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg 2006; 103:21-37
SNIECINSKI RM, CHANDLER WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113:1319-33
LOMBARD FW, GRICHNIK KP. Update on management strategies for separation from cardiopulmonary bypass. Curr Opin Anaesthesiol 2011; 24:49-57
MURPHY GS, HESSEL EA, GROOM RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108:1394-417
WARREN OJ, SMITH AJ, ALEXIOU C, et al. The inflammatory response to cardiopulmonary bypass: Part 1 – Mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23: 223-31
WARREN OJ, WATRET AL, DE WIT KL, et al. The inflammatory response to cardiopulmonary bypass: Part 2 – Anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth 2009; 23: 384-93

 

Références

1 ABAH U, ROBERTS PG, ISHAQ M, et al. Is cold or warm cardioplegia superior for myocardial protection ? Interact Cardiovasc Thorac Surg 2012 ; 14 :848-55
2 ABU-OMAR Y, BALACUMARASWAMI L, PIGOTT DW, et al. Solid and gazeous cerebral micro-embolization during off-pump, on-pump and open cardiac surgery procedures. J Thorac Cardiovasc Surg 2004; 127:1759-65
3 ACHNECK HE, SILESHI B, PARIKH A, et al. Pathophysiology of bleeding and clotting in the cardiac surgery patient. Circulation 2010; 122:2068-77
4 ADAMS DC, HEYER EJ, SIMON AE, et al. Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med 2000; 28:309-11
5 AGLIO LS, STANFORD GG, MADDI R, et al. Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5:201-8
6 ALGHAMDI AA, LATTER DA. Pulsatile versus nonpulsatile cardiopulmonary bypass flow: an evidence-based approach. J Card Surg 2006; 21:347-54
7 ANGELI E. The crystalloid cardioplegia: advantages with a word of caution. Ann Fr Anesth Réan 2011; 30:S17-S19
8 AUGOUSTIDES JGT. The inflammatory response to cardiac surgery with cardiopulmonary bypass : shoud steroid prophylaxis be routine ? J Cardiothorac Vasc Anesth 2012 ; 26 :952-8
9 Agoustides JGT, Weiss SJ, Weiner J, et al: Diagnosis of patent foramen ovale with multiplane transesophageal echocardiography in adult cardiac surgical patients. J Cardiothorac Vasc Anesth 2004; 18:725-30
10 ALDEA GS, DOURSOUNIAN M, O’GARA P, et al. Heparin-bounded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg 1996; 62:410-7
11 ANDROPOULOS DB, STAYER SA, DIAZ LK, RAMAMOORTHY C. Neurological monitoring for congenital heart surgery. Anesth Analg 2004; 99:1365-75
12 ANGELI E. The crystalloid cardioplegia: advantages with a word of caution. Ann Fr Anesth Réan 2011; 30:S17-S19
13 ANTOGNINI J. Hypothermia eliminates isoflurane requirements at 20 degrees celsius. Anesthesiology 1993; 78:1152-7
14 AOKI M, NORMURA F, STROMSKI ME, et al. Effects of pH on brain energetics after hypothermic circulatory arrest. Ann Thorac Surg 1993; 55:1093-1103
15 AOUIFI A, PIRIOU V, BASTIEN O, et al. Severe digestive complications after heart surgery using extracorporeal circulation. Can J Anaesth 1999; 46:114-21
16 ARONSON S, BLUMENTHAL R. Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothor Vasc Anesth 1998; 12:567-86
17 ARROWSMITH JE, GROCOTT HP, REVES JG, et al. Central nervous system complications of cardiac surgery. Br J Anaesth 2000; 84:378-93
18 ASIMAKOPOULOS G. The inflammatory response to CPB: the role of leucocyte filtration. Perfusion 2002; 17:7-10
19 AVIDAN MS, JACOBSOHN E, GLICK D, et al. Prevention of intraoperative awareness in a high-risk surgical population. N Engl J Med 2011; 365:591-600
20 AZMOON S, DEMAREST C, PUCILLO AL, et al. Neurologic and cardiac benefits of therapeutic hypothermia. Cardiol Rev 2011; 19:108-14
21 BAILEY JM, LEVY JH, KIKURA M. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 1994; 81:616-22
22 BARVAIS L, HEITZ D, SCHMARTZ D, et al. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: Assessment of the prospective predictive accuracy and the quality of anesthesia. J Cardiothorac Vasc Anesth 2000; 14:402-8
23 BARVAIS L, RAUSIN I, GLEN JB, et al. Administration of propofol by target-controlled infusion in patients undergoing coronary artery surgery. J Cardiothorac vasc Anesth 1996; 10:877-83
24 BAR-YOSEF S, ANDERS M, MACKENSEN GB, et al. Aortic atheroma burden and cognitive dysfunction after coronary artery bypass graft surgery. Ann Thorac Surg 2004; 78:1556-62
25 BAUFRETON C, MOREAU X, CORBEAU JJ, et al. Déroulement de la CEC standard et avec les nouveaux dispositifs consommables. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, pp 113-45
26 BAZARAL MG, PETRE J, NOVOA R. Errors in thermodilution cardiac output measurements caused by rapid pulmonary artery temperature decreases after cardiopulmonary bypass. Anesthesiology 1992; 77:31-37
27 BEATTIE WS, KARKOUTI K. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg 2006; 103:1360-4
28 BECK JR, PARK DY, MONGERO LB. Canulation and clinical concerns for cardiopulmonary bypass access. In: MONGERO LB, BECK JR (eds). On bypass. Advanced perfusion techniques. Totowa (NJ, USA): Humana Press 2010, 171-191
29 BEIERLEIN W, SCHEULE AM, DIETRICH W, et al. Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions. Ann Thorac Surg 2005; 79:7412-8
30 BELLOMO R, CHAPMAN M, FINFER S, et al. Low-dose dopamine in patients with early renal dysfunction: A placebo controlled randomized trial. Lancet 2000; 356:2139-43
31 BENJO A, THOMPSON RE, FINE D, et al. Pulse pressure is an age-independent predictor of stroke development after cardiac surgery. Hypertension 2007; 50:630-5
32 BENTLEY JB, CONAHAN TJ, CORK RC. Fentanyl sequestration in lungs during cardiopulmonary bypass. Clin Pharmacol Ther 1983;34:703-6
33 BERNARD F, DENAULT A, BABIN D, et al. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg 2001; 92:291-8
34 BERRIZBEITA LD, TESSLER S, JACOBOWITZ IJ, et al. Effect of sternotomy and coronary artery bypass surgery on postoperative pulmonary mechanics. Chest 1989; 96:873-6
35 BETTEX DA, CHASSOT PG. Echocardiographie transoesophagienne en anesthésie réanimation. Paris, Pradel-Masson, 1997
36 BETTEX DA, SCHMIDLIN D, BERNATH MA, PRETRE R, HURNI M, CHASSOT PG. Intraoperative transesophageal echocardiography in pediatric congenital cardiac surgery: A two-center observational study. Anesth Analg 2003; 97:1275-82
37 BIANCARI F, RIMPILAINEN R. Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart 2009; 95:964-9
38 BIRNBAUM DE. Extracorporeal circulation in non-cardiac surgery. Eur J Cardiothorac Surg 2004; 26:S82-5
39 BISSONNETTE B, HOLTBY HM, PUA DAJ, ET AL. Cerebral hyperthermia in children after cardiopulmonary bypass. Anesthesiology 2000; 93:611-8
40 BLAUTH CI. Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg 1995; 59:1300-3
41 BODY SC, MAZER CD. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg 2006; 103:1354-9
42 BOLDT J. Volume therapy in cardiac surgery: Are Americans different from Europeans ? J Cardiothorac Vasc Anesth 2006; 20:98-105
43 BOLDT J, BROSCH C, LEHMANN A, et al. Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. Ann Thorac Surg 2001; 71:1524-9
44 BOLDT J, KING D, SHELD HH, et al. Lung management during cardiopulmonary bypass: Influence on extravascular lung water. J Cardiothorac Vasc Anesth 1990; 4:73-8
45 BOODHWANI M, WILLIAMS K, BABAEV A, et al. Ultrafiltration reduces blood transfusion following cardiac surgery: a meta-analysis. Eur J Cardiothorac Surg 2006; 30:892-7
46 BORGER MA, RAO V. Temperature management during cardiopulmonary bypass: Effect of rewarming rate on cognitive dysfunction. Semin Cardiothorac Vasc Anesth 2002; 6:17-20
47 BOSTON US, SLATER JM, ORSZULAK TA, et al. Hierarchy of regional oxygen delivery during cardiopulmonary bypass. Ann Thorac Surg 2001; 71:260-4
48 BOVILL J, SEBEL P. Pharmacokinetics of high-dose fentanyl: A study in patients unergoing cardiac surgery. Br J Anaesth 1980; 52:795-9
49 Bowles BJ, Lee JD, Dang CR, et al. Coronary artery bypass performed without the use of cardiopulmonary bypass is associated with reduced cerebral microemboli and improved clinical results. Chest 2001; 119: 25-30
50 BOYD WC, THOMAS SJ. Pro: Magnesium should be administered to all coronary artery bypass graft surgery patients undergoing cardiopulmonary bypass. J Cardiothorac vasc Anesth 2000; 14:339-43
51 BRACKEN CA, GURKOWSKI MA, NAPLES JJ, et al. Cardiopulmonary bypass in two patients with previously undetected cold agglutinins. Case Conference. J Cardiothorac Vasc Anesth 1993; 7:743-9
52 BRANDT RR, OH JK, ABEL MD, et al. Role of emergency intraoperative transesophageal echocardiography. J Am Soc Echocardiogr 1998; 11:972-7
53 BREZIS M, ROSEN S. Hypoxia of the renal medulla – its implications for disease. N Engl J Med 1995; 332:647-55
54 BRIENZA N, GIGLIO MT, MARUCCI M, FIORE T. Does perioperative hemodynamic optimization protect renal function in surgical patients ? A meta-analytic study. Crit Care Med 2009; 37: 2079-90
55 BROGDEN RN, MARKHAM A. Fenoldopam: a review of its pharmacodynamic and pharmacokinetics properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies. Drugs 1997; 54:634-50
56 BROOKER RF, BROWN WR, MOODY DM, et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 1998; 65:1651-8
57 BROWN CB, OGG CS, CAMERON JS. High-dose furosemide in acute renal failure: A controlled clinical trial. Clin Nephrol 1991; 15:90-6
58 BROWN DJA, BRUGGER H, BOYD J, et al. Accidental hypothermia. N Engl J Med 2012; 367:1930-8
59 BROWN JR, BIRKMEYER NJO, O’CONNOR GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007; 225:2801-13
60 BROWN WR, MOODY DM, CHALLA VR, et al. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke 2000; 31:707-13
61 BRUTSAERT DL, SYS SU, GILLEBERT TC. Diastolic dysfunction in post-cardiac surgical management. J Cardiothor Vasc Anesth 1993; 7(suppl 1):18-20
62 BUCKBERG GD. Strategies and logic of cardioplegic delivery to prevent, avoid and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg 1987; 93:127-35
63 BUYLAERT W, HERREGODS L, MORTIER L, et al. Cardiopulmonary bypass and the pharmacokinetics of drugs. Clin Pharmacokinet 1989; 17:10-5
64 BUZELLO W, SCHLUERMANN D, POLLMAECHER T, et al. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 1987; 66:842-6
65 Calafiore AM, Di Mauro M, Teodori G, et al. Impact of aortic manipulation on incidence of cerebrovascular accidents after surgical myocardial revascularization. Ann Thorac Surg 2002; 73: 1387-93
66 CALAFIORE AM, TEODORI G, MEZZETTI A, et al. Intermittent antegrade warm blood caredioplegia. Ann Thorac Surg 1995; 59:398-402
67 CALDERON J, SIGONNEY P, JANVIER G. MECC: minimal extra-corporeal circulation. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, pp 541-7
68 CAPPABIANCA G, ROTUNNO C, DE LUCA TUPPUTI L, et al. Protective effects of steroids in cardiac surgery: A meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth 2011; 25:156-65
69 CARCOANA OV, MATHEW JP, DAVIS E, et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial. Anesth Analg 2003; 97:1222-9
70 CASATI V, GUZZON D,OPPIZZI M, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogenic transfusions. J Thorac Cardiovasc Surg 2000; 120:520-7
71 CHAMBERS DJ, SAKAI A, BRAIMBRIDGE MV, et al. Clinical validation of St. Thomas’s Hospital cardioplegic solution No. 2 (Plegisol). Eur J Cardiothorac Surg 1989; 3:346-52
72 CHANDLER WL, VELAN T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 2003; 101:4355-62
73 CHANDLER WL, VELAN T. Plasmin generation and D-dimer formation during cardiopulmonary bypass. Blood Coag Fibrinolysis 2004; 15:583-91
74 CHASSOT PG. Analyse rétrospective et prospective de 12’986 échocardiographies transoesophagiennes peropératoires. CHUV, 2008. Données non-publiées
75 Cheng DC, Bainbridge D, Martin JE, Novick RJ. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 2005; 102:188-203
76 CHERTOW GM, BURDICK E, HONOUR M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16:3365-70
77 CHEW MS, BRIX-CHRISTENSEN V, RAVN HB, et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion 2002; 17:327-33
78 CHIOLERO R, BORGEAT A, FISCHER A. Postoperative arrhythmias and risk factors after open heart surgery. J Thorac Cardiovasc Surg 1991; 39:81-4
79 Christoforidis D, Chassot PG, Mosimann F, et al: Isolated limb perfusion: distinct tourniquet and tumor necrosis factor effects on the early hemodynamic response. Arch Surg 2003; 138:17-25
80 CHUA J, SCHWARZENBERGER J, MAHAJAN A. Optimization of pacing after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2012; 26:291-301
81 CLEVELAND JC, SHROYER AL, CHEN AY, et al. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 2001; 72:1282-8
82 COLEMAN CI, RIGALI VT, HAMMOND J, et al. Evaluating the safety implications of aprotinin use: The Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS). J Thorac Cardiovasc Surg 2007; 133:1547-52
83 COLEMAN MD, SHAEFI S, SLADEN RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anesthesiol 2011; 24:70-6
84 COOK DJ. Neurologic effects. In: GRAVLEE GP (ed). Cardiopulmonary bypass. 2nd edition. Philadelphia, Lippincott, Williams & Wilkins, 2000, pp 403-31
85 COOK DJ. Con: Temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter ? Anesth Analg 2009; 109:1733-7
86 CROUGHWELL ND, NEWMAN NF, BLUMENTHAL JA, et al. Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1994; 58:1702-8
87 CROUGHWELL ND, NEWMAN NF, LOWRY E, et al. Effect of temperature during cardiopulmonary bypasson gastric mucosal perfusion. Br J Anaesth 1997; 78:34-8
88 Czerny M, Baumer H, Kilo J, et al. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 2000; 17: 737-42
89 DASTA J, JACOBI J, WU LS. Loss of nitroglycerin to cardiopulmonary bypass apparatus. Crit Care Med 1983; 11:50-2
90 DAVILA-ROMAN VG, BARZILAI B, WAREING TH, et al. Atherosclerosis of the ascending aorta. Stroke 1994; 25:2010-16
91 DAVILA-ROMAN VG, BARZILAI B, WAREING TH, et al. Intraoperative ultrasonographic evaluation of the ascending aorta in 100 consecutive patients undergoing cardiac surgery. Circulation 1991; 84(Suppl III):47-53
92 DAVIS RF, THOMPSON J. Technology, pathophysiology and pharmacology of cardiopulmonary bypass. In: THYS DM, et al Eds. Textbook of cardiothoracic anesthesiology. New York, McGraw-Hill Co, 2001,354-75
93 DAWSON PJ, BJORKSTEN AR, BLAKE DW, et al. The effects of cardiopulmonary bypass on total and unbound plasma concentration of propofol and midazolam. J Cardiothorac Vasc Anesth 1997; 11:556-61
94 DE COCK CC, GIUDICI MC, TWISK JW, et al. Comparison of the haemodynamic effects of right ventricular outflow tract pacing with right ventricular apex pacing. A quantitative review. Europace 2003; 5:275-8
95 DECOENE C. La cardioplégie sanguine: avantages et inconvéniuents. Ann Fr Anesth Réan 2011; 30:S20-S22
96 DE FOE GR, ROSS CS, OLMSTEAD EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 2001; 71:769-76
97 DE HOYOS A, DEMAJO W, SNELL G, et al. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg 1993; 106:787-96
98 Demaria RG, Carrier M, Fortier S, et al. Reduced mortality and strokes with off-pump artery bypass grafting surgery in octogenarians. Circulation 2002; 106(suppl I):I-5-10
99 DEPOIX JP, BERROETA C, PAQUIN S. Conduites pratiques en circulation extracorporelle. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, 571-80
100 DENAULT A, DESCHAMPS A, MURKIN JM. A proposed algorithm for the intraoperative use of cerebral near-infrared spectroscopy. Semin Cardiothorac Vasc Anesth 2007; 11:274-81
101 DIEFENBACH C, ABEL M, BUZELLO W. Greater neuromuscular blocking potency of atracurium during hypothermic than during normothermic cardiopulmonary bypass. Anesth Analg 1992; 75:675-8
102 Diegeler A, Doll N, Rauch T, et al. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, «off-pump» technique, and conventional cardiopulmonary bypass. Circulation 2000; 102: III95-100
103 DOBLAR DD. Cerebrovascular assessment of the high-risk patient: The role of transcranial Doppler ultrasound. J Cardiothorac Vasc Anesth 1996; 10:3-14
104 DOOLAN LA, JONES EF, KALMAN J, et al. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothor Vasc Anesth 1997; 11:37-41
105 DURRER B, BRUGGER H, SYME D. The medical on-site treatment oh hypothermia. ICAR-MEDCOM recommendation. High Alt Med Biol 2003; 4:99-103
106 Eggimann P, Chiolero R, Chassot PG, et al: Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. Chest 1995; 107:1074-82
107 EISING GP, PFAUDER M, NIEMEYER M, et al. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery ? Ann Thorac Surg 2003; 75:23-7
108 ELAHI MM, YII M, MATATA BM. Significance of oxidants and inflammatory mediators in blood of patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2008; 22:455-67
109 ELTZSCHIG HK, Rosenberger p, löffler m, et al. Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg 2008;85 :845-53
109a EMA-European Medicines Agency. European Medicines Agency recommends lifting suspension of aprotinin 2011.
http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Antifibrinolytic_medicines/WC500122924.pdf
110 ENGLAND MR. The changes in bispectral index during a hypovolemic cardiac arrest. Anesthesiology 1999; 91:1947-9
111 FAN Y, ZHANG AM, XIAO YB, et al. Warm versus cold cardioplegia for heart surgery: A meta-analysis. Eur J Cardiothorac Surg 2010; 37:912-9
112 FEDOROW C, GROCOTT H. Cerebral monitoring to optimize outcomes after cardiac surgery. Curr Opin Anaesthesiol 2010; 23:89-94
113 FEDULLO AJ, LERNER RM, GIBSON J, et al. Sonographic measurement of diaphragmatic motion after coronary artery bypass surgery. Chest 1992; 102:1683-6
114 FERGUSSON DA, HEBERT PC, MAZER CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358:2319-31
115 FERRARIS VA, FERRARIS SP, SAHA SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg 2007; 83:S27-S86
116 FIACCADORI E, VEZZANI A, COFFRINI E, et al. Cell metabolism in patients undergoing major valvular surgery: relationship with intra and postoperative hemodynamics, oxygen transport, and oxygen utilization patterns. Crit Care Med 1989; 17:1286-91
117 FLEZZANI P, ALVIS J, JACOBS J. Sufentanil disposition during cardiopulmonary bypass. Can J Anaesth 1987; 34:566-72
118 FLYNN P, HUGHES R, WALTON B. Use of atracurium in cardiac surgery involving cardiopulmonary bypass with induced hypothermia. Br J Anaesth 1984; 56:967-82
119 FONTES ML, MATHEW JP, RINDER HM, et al. Atrial fibrillation after cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 2005; 101:17-23
120 FRÄSSDORF J, DE HERT S, SCHLACK W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth 2009; 103:89-98
121 FROMES Y, GAILLARD D, PONZIO O, et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002; 22:527-33
122 FRUMENTO RJ, LEE D, OZ MC, et al. N-acetylcysteine and total antioxydant status in high-risk cardiac surgical patients. Anesth Analg 2002; 93:SCA16
123 GARWOOD S. Cardiac surgery-associated acute renal injury: New paradigms and innovative therapies. J Cardiothorac Vasc Anesth 2010; 24:990-1001
124 GEISSLER HJ, ALLEN JS, MEHLHORN U, et al. Cooling gradients and formation of gazeous microemboli with cardiopulmonary bypass: an echocardiographic study. Ann Thorac Surg 1997; 64:100-8
125 GERHARDT MA, BOOTH JV, CHESNUT LC, et al. Acute myocardial beta-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease. Circulation 1998; 98:II275-II281
126 GIBBON JH. Application of the mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 36:171-85
127 GIRARD C. CEC et inflammation. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, pp 147-55
128 GOLD JP, CHARLESON MD, WILLIAMS-RUSSO P, et al. Improvement in outcomes after CABG. A randomized trial comparing intraoperative high versus mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110:1302-14
129 GORMLEY SMC, McBRIDE WT, ARMSTRONG MA, et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 2002; 17:61-5
130 GRIES A, BODE C, GROSS S, et al. The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery. Anesth Analg 1999; 88:1213-9
131 GRIFFIN MG, HINES RL. Management of perioperative ventricular dysfunction. J Cardiothorac Vasc Anesth 2001; 15:90-106
132 GRIGORE AM, GROCOTT HP, MATHEW JP, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg 2002; 94:4-10
133 GRIGORE AM, MATHEW JP. Con: Magnesium should not be administered to all coronary artery bypass graft surgery patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14:344-46
134 GRIGORE AM, MURRAY CF, RAMAKRISHNA H, DJAIANI G. A core review of temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarmning rate matter ? Anesth Analg 2009; 109:1741-51
135 GROCOTT HP, HOMI HM, PUSKAS F. Cognitive dysfunction after cardiac surgery: revisiting etiology. Semin Cardiothorac vasc Anesth 2005; 9:123-9
136 GROCOTT HP, MACKENSEN B, GRIGORE AM, et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke 2002; 33:537-41
137 GROVER FL. The Society of thoracic Surgeons national Database. Current status and future directions. Ann Thorac Surg 1999; 68:367-73
138 GUIBAUD JP, OUEDRAOGO N, JANVIER G. Traitements de surface des matériels hémocompatibles pour le CEC. . In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, pp 109-12
139 GUNAYDIN S, FARSAK B, KOKAKULAK M, et al. Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits. Ann Thorac Surg 2002; 74:819-24
140 HAASE M, HAASE-FIELITZ A, BELLOMO R, et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009; 37:39-47
141 HABIB RH, ZACHARIAS A, SCHWANN TA, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed ? J Thorac Cardiovasc Surg 2003; 125:1438-50
142 HABIB RH, ZACHARIAS A, SCHWANN TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 2005; 33:1749-56
143 HAGA KK, McCLYMONT KL, CLARKE S, et al. The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity. A systematic review and meta-analysis. J Cardiothorac Surg 2011; 6:3
144 HALL RI. Cardiopulmonary bypass and the systemic inflammatory response: Effects on drug actions. J Cardiothorac Vasc Anesth 2002; 16:83-98
145 HALL TS. The pathophysiology of cardiopulmonary bypass: The risks and benefits of hemodilution. Chest 1995: 100:88-94
146 HAMMAREN E, YLI-HANKALA A, ROSENBERG PH, et al. Cardiopulmonary bypass-induced changes in plasma concentration of propofol and in auditory evoked potentials. Br J Anaesth 1996; 77:360-4
147 HAYASHIDA N, SHOUJIMA T, TESHIMA H, et al. Clinical outcomes after cardiac operations in patients with cirrhosis. Ann Thorac Surg 2004; 77:500-5
148 HAYON SONSINO D, d’ATTELIS N. Hémodilution au cours et au décours de la circulation extracorporelle. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, pp 229-40
149 HENNEIN HA. Inflammation after cardiopulmonary bypass: therapy for the postpump syndrome. Semin Cardiothorac Vasc Anesth 2001; 5:236-55
150 HERBERT JM, HERAULT JP, BERNAT A, et al. Biochemical and pharmacological properties of SANORG 340006, a potent and long acting synthetic pentasaccharide. Blood 1998; 91:4197-205
151 HERINGLAKE M, GARBERS C, KÄBLER JH, et al. Preoperative cerebral oxygen saturation and clinical outcomes in cardiac surgery. Anesthesiology 2010; 114:58-69
152 HESSEL EA. Cardiopulmonary bypass equipment. In: ESTEFANOUS FG, et al. Eds. Cardiac anesthesia. Principles and clinical practice, 2nd edition. Philadelphia, Lipincott Williams & Wilkins, 2001, 335-86
153 HESSEL EA, HILL AG. Circuitry and canulation techniques. In: GRAVLEE GP (ed). Cardiopulmonary bypass: principles and practice, 2nd edition. Philadelphia: Lippincott, Williams & Wilkins, 2000, p 70
154 HO PM, ARCINIEGAS DB, GRIGSBY J, et al. Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg 2004; 77:597-603
155 HOGUE CW, LONDON MJ. Aprotinin use during cardiac surgery: A new or continuing controversy ? Anesth Analg 2006; 103:1067-70
156 HOGUE CW, PALIN CA, ARROWSMITH JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg 2006; 103:21-37
157 HONAN D, DOHERTY D, FRIZELLE H. A comparison of the effects on bispectral index of mild vs moderate hypothermia during cardiopulmonary bypass. Eur J Anaesthesiol 2006; 14:1-6
158 HONKONEN EL, KAUKINEN L, PEHKONEU EJ, et al. Myocardial cooling and right ventricular function in patients with right coronary artery disease: antegrade vs retrograde cardioplegia. Acta Anaesthesiol Scand 1997; 41:287-95
159 HOOVER LR, DINAVAHI R, CHENG WP, et al. Jugular venous oxygenation during hypothermic cardiopulmonary bypass in patients at risk for abnormal cerebral autoregulation: influence of –stat versus pH-stat blood gas management. Anesth Analg 2009; 108:1389-93
160 HORNICK P, TAYLOR K. Pulsatile and non-pulsatile perfusion: the continuing controversy. J Cardiothorac Vasc Anesth 1997; 11: 310-6
161 HUDSON RJ, THOMPSON IR, JASSAL R, et al. Cardiopulmonary bypass has minimal effect on the pharmacokinetics of fentanyl in adults. Anesthesiology 2003; 99:847-54
162 HYNYNEN M. Binding of fentanyl and alfentanil to the extracorporeal circuit. Acta Anaesthesiol Scand 1987; 31:706-10
163 HYNYNEN M, HAMMAREN E, ROSENBERG PH. Propofol sequestration within the extracorporeal circuit. Can J Anaesth 1994; 41:583-8
164 INNERHOFER P, KIENAST J. Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol 2010; 24:1-14
165 IP-YAM PC, MURPHY S, BAINES M, et al. Renal function and proteinuria after cardiopulmonary bypass: The effects of temperature and mannitol. Anesth Analg 1994; 78:842-847
166 IRISH CL, MURKIN JM, CLELAND A, et al. Neuromuscular blockade significantly decreases systemic oxygen consumption during hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1991; 5:132-7
167 ISETTA C, CADUSSEAU JL. Circuits de circulation extracorporelle: matériels réutilisables, matériels à usage unique. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, 59-86
168 JOBES DR. Safety issues in heparin and protamin administration for extracorporeal circulation. J Cardiothorac Vasc Anesth 1998; 12:17-20
169 JONAS RA. Hypothermia, circulatory arrest, and the pediatric brain. J Cardiothorac Vasc Anesth 1996; 10:66-74
170 JONAS RA, WYPIJ D, ROTH SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg 2003; 126:1765-74
171 JONES T, ROY RC. Should patients be normothermic in the immediate postoperative period ? Ann Thorac Surg 1999; 68:1454-5
172 JOSHI B, BRADY K, LEE J, et al. Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke. Anesth Analg 2010; 110:321-8
173 JOSHI B, ONO M, BROWN C, et al. Predicting the limits of cerebral autoregulation during cardioplumonary bypass. Anesth Analg 2012; 114:503-10
174 JOURNOIS D, BOURDARIAS B. Hémofiltration en chirurgie cardiaque. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, 377-85
175 JOURNOIS D, ISRAEL-BIET E, POUARD P, et al. High volume, zero-balance hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996; 85:965-1003
176 JULIER K, DA SILVA R, GARCIA C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery. Anesthesiology 2003; 98:1315-27
177 KALLMEYER IJ, COLLARD CD, FOX JA, et al. The safety of intraoperative transesophageal echocardiography. Anesth Analg 2001; 92:1126-30
178 KARKOUTI K, BEATTIE WC, DATTILO KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006; 46:327-38
179 KARKOUTI K, DJAIANI G, BORGER MA; et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 2005; 80:1381-7
180 KARKOUTI K, WIJEYSUNDERA DN, YAU TM, et al. Acute kidney injury after cardiac surgery. Focus on modifiable risk factors. Circulation 2009; 119:495-502
181 KARKOUTI K, WIJEYSUNDERA DN, YAU TM, et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and non-anemic patients. Anesthesiology 2011; 115:523-30
182 KERN FH, UNGERLEIDER RM, REVES JG, et al. The effect of altering pump flow rate on cerebral blood flow and cerebral metabolism in neonates, infants and children. Ann Thorac Surg 1993; 58:1366-72
183 KIKURA M, SATO S. The efficacy of preemptive milrinone or amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg 2002; 94:22-30
184 KILGER E, WEISS F, BRIEGEL J, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-74
185 KIM KB, KANG CH, CHANG WI, et al. Off-pump coronary artery bypass with complete avoidance of aortic manipulation. Ann Thorac Surg 2002; 74:S1377-82
186 KIMMEL SE, SEKERES M, BERLIN JA, et al. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg 2002; 94:1402-8
187 KINCAID EH, ASHBURN DA, HOYLE JR, et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery ? Ann Thorac Surg 2005; 80:1388-93
188 KLEMPERER JD, KLEIN I, GOMEZ M, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995; 333:1522-7
189 KONSTADT SN, REICH DL, KAHN R, et al. Transesophageal echocardiography can be used to screen for ascending aortic atherosclerosis. Anesth Analg 1995; 81:225-33
189a KOSTER A, BÖREGERMANN J, ZITTERMANN A, et al. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013; 110:34-40
190 KOSTER A, SCHIRMER U. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Curr Opin Anaesthesiol 2011; 24:92-7
191 KRAJEWSKI S, KURZ J, NEUMANN B, et al. Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracoroporeal circulation and hypothermia. Br J Anaesth 2012; 108:912-21
192 KUGELBERG J, SCHULLER H, BERG B, et al. Treatment of accidental hypothermia. Scand J Thorac Cardiovasc Surg 1967; 1:142-6
193 KUMAR K, CRANKSHAW DP, MORGAN DJ, et al. The effect of cardiopulmonary bypass on plasma protein binding of alfentanil. Eur J Clin Pharmacol 1988; 35:47-52
194 KUMLE B, BOLDT J, SUTTNER SW, et al. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 2003; 75:1558-64
195 KURUSZ M. Lessons from perfusion surveys. Perfusion 1997; 12:221-8
196 KURUSZ M, WHEELDON DR. Risk containment during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg 1990; 2:400-9
197 Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-52
198 LANDOW L, WILSON J. An improved lidocaine infusion protocol for cardiac surgical patients. J Cardiothorac Vasc Anesth 1991; 5:209-13
199 LANGE M, ERTMER C, VAN AKEN H, et al. Intravascular volume therapy with colloids in cardiac surgery. J Cardiothorac Vasc Anesth 2011; 25:847-55
200 LANIER WL. Glucose management during cardiopulmonary bypass: cardiovascular and neurologic implications. Anesth Analg 1991; 72:423-7
201 LASSNIGG A, DONNER E, GRUBHOFER G, et al. Lack of renoprotective effects od dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000; 11:97-104
202 LAVIGNE D, Vasopressin and methylene blue: alternate therapies in vasodilatory shock. Semin Cardiothorac Vasc Anesth 2010; 14:186-9
203 Lejeune FJ, Kroon BB, Di Filippo F, et al: Isolated limb perfusion: the European experience. Surg Oncol Clin N Am 2001; 10:821-32
204 LEVI A, CROMHEECKE ME, DE JONGE E, et al. Blood loss in cardiac surgery: a meta-analysis of clinical relevant endpoints. Lancet 1999; 354:1940-7
205 LIAKOPOULOS OJ, CHOI YH, HALDENWANG PL, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients. Eur Heart J 2008; 29:1548:59
206 LIAM BL, PLOCHL W, COOK DJ, et al. Hemodilution and whole body balance during normothermic cardiopulmonary bypass. J Cardiothorac vasc Surg 1998; 115:1203-8
207 LICINA MG, SAVAGE RM, HEARN CH, KRAENZLER EJ. The role of transesophageal echocardiographhy in perfusion management. Semin Cardiothorac Vasc Anesth 2001; 5:321-34
208 LICKER M, SCHWEIZER A. Vasopressin and postcardiopulmonary bypass refractory hypotension. Anesth Analg 1999; 88:695
209 LIMATHE J, ATMACA N, MENGHESHA, D, KRIAN A. Combined procedures using the extracorporeal circulation and urologic tumor operation - experiences in six cases. Interact Cardiovasc Surg 2004; 3:132-5
210 LIU YH, WANG DX, LI LH, et al. The effects of cardiopulmonary bypass on the number of cerebral microemboli and the incidence of cognitive dysfunction after coronary artery bypass graft surgery. Anesth Analg 2009; 109:1013-22
211 LOMBARD FW, GRICHNIK KP. Update on management strategies for separation from cardiopulmonary bypass. Curr Opin Anaesthesiol 2011; 24:49-57
212 LOWENSTEIN E, ZAPOL WM. Protamine reactions, explosive mediator release and pulmonary vasoconstriction. Anesthesiology 1990; 73:373-8
213 LOZANO S, MOSSAD E. Cerebral function monitors during pediatric cardiac surgery: can they make a difference ? J Cardiothorac Vasc Anesth 2004; 18:645-56
214 LUCIANI GB, MENON T, VECCHI B, et al. Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective randomized clinical study. Circulation 2001: 104:1253-9
215 LUND C, HOL PK, LUNDBLAD R, et al. Comparison of cerebral embolization during off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg 2003; 76:765-70
216 MACKAY JH, FEERICK AE, WOODSON LE, et al. Increasing organ blood flow during cardiopulmonary bypass in pigs: Comparison of dopamine and perfusion pressure. Crit Care Med 1995; 23:1090-8
217 MAGNUSSON L, ZEMGULIS V, RENLING A, et al. Use of a vital capacity maneuver to prevent atelectasis after cardiopulmonary bypass. Anesthesiology 1998; 88:134-42
218 MAHARAJ C, LAFFEY JG. New strategies to control the inflammatory response in cardiac surgery. Curr Opin Anesthesiol 2004; 17:35-48
219 MAITRE P, FUNK B, CREVOISIER C, et al. Pharmacokinetics of midazolam in patients recovering from cardiac surgery. Eur J Clin Pharmacol 1989; 37:161-6
220 MANGANO DT, MIAO Y, VUYLSTEKE A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297:471-9
221 MANGANO DT, TUDOR I, DIETZEL C, et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-65
222 MANGOUSH O, PURKAYASTHA S, HAJ-YAHIA S, et al. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 2007; 31:1058-69
223 MANSON L, WEITZ JI, PODOR TJ, et al. The variable anticoagulant response to unfractioned heparin in vivo reflects binding to plasma proteins rather than clearance. J Lab Clin Med 1997; 130:649-655
224 MARASCO SF, SHARWOOD LN, ABRAMSON MJ. No improvement in neurocognitive outcomes after off-pump versus on-pump coronary revascularisation: A meta-analysis. Eur J Cardiothorac Surg 2008; 33:961-70
225 MARIK PE. Low-dose dopamine: a systematic review. Intens Care Med 2002; 28:877-83
226 MARTIN K, WIESNER G, BREUER T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107:1783-90
227 MASLOW AD, REGAN MM, PANZICA P, et al. Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction. Anesth Analg 2002; 95:1507-18
228 MAZZARELLA V, TACCONE GM, TOZZI C, et al. Renal functions in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1992; 104:1625-7
229 McCULLOUGH JN, ZHANG N, REICH DL, et al. Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg 1999; 67:1895-931
230 McKINDLEY DS, HANES S, BOUCHER BA. Hepatic drug metabolism in critical illlness. Pharmacotherapy 1998; 18:759-78
230a McMULLAN V, ALSTON RP. Aprotinin and cardiac surgery : a sorry tale of evidence misused. Br J Anaesth 2013 ; 110 : 675-8
231 MEBAZAA A, NIEMINEN MS, PACKER M, et al. Levosimendan versus dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 2007; 297:1883-91
232 MEHTA RL, KELLUM JA, SHAH SV, et al. Acute Kidney Injury Network : report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 ; 11 : R31
233 MEJAK BL, STAMMERS A, RAUCH E, et al. A retrospective study on perfusion incidents and safety devices. Perfusion 2000; 15:51-9
234 Menasche P. The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Ann Thorac Surg 2001; 72: S2260-5; discussion S5-6
235 MENKIS AH. Management of the ascending aorrta in routine cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8:19-24
236 MESSENT M, SULLIVAN K, KEOGH BF, et al. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia 1992; 47: 267-8
237 METZ B, REICH NT, MELLAS N, et al. Desflurane pharmacokinetics during cardiopulmonary bypass. J Cardiothorac vasc Anesth 2001; 15:179-82
238 MICHAELS IK, NEUSTEIN SM. Sudden hypotension before cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1998; 12:231
239 MICHEL-CHERQUI M, CEDDAHA A, LIU N, et al. Assessment of systematic use of intraoperative trasesophageal echocardiography during cardiac surgery in adults: A prospective study of 203 patients. J Cardiothorac Vasc Anesth 2000; 14:45-50
240 MITCHENFELDER JD. The awake brain. In: Anesthesia and the brain. New-York: Churchill-Livingstone, 1988, 7-8
241 MITCHENFELDER JD, MILDE JH. The relationship among canine brain temperature, metabolism and function during hypothermia. Anesthesiology 1991; 75:130-6
242 MONGERO LB, BECK JR (eds). On bypass. Advanced perfusion techniques. Policy and procedure guidelines (CP36): Cold agglutinins. Totowa (NJ, USA): Humana Press 2010, 426-8
243 MOORE RA, GELLER EA, GALLAGHER JD, et al. Effect of hypothermic cariopulmonary bypass on nitroprusside metabolism. Clin Pharmacol Ther 1985; 37:680-3
244 MORDECAI MM, MURRAY MJ. The value of team wotk. J Cardiothorac Vasc Anesth 2006; 20:1-2
245 MORIMOTO Y, NIIDA Y, HISANO K, et al. Changes in cerebral oxygenation in children undergoing surgical repair of ventricular septal defects. Anaesthesia 2003; 58:77-83
246 MUKADAM ME, PRITCHARD D, RIDDINGTON D, et al. Case 7-2001. Management during cardiopulmonary bypass of patients with presumed fish allergy. J Cardiothorac Vasc Anesth 2001; 15:512-9
247 MURKIN JM. Adverse central nervous system outcomes after cardiopulmonary bypass. A beneficial effect of aprotinin ? Semin Cardiothorac Vasc Anesth 2001; 5:282-5
248 MURKIN JM. Neurocognitive outcomes: the year in review. Curr Opin Anesthesiol 2005; 18:57-62
249 MURKIN JM, FARAR JK, TWEED WA. Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: the influence of PaCO2. Anesth Analg 1987; 66:825-32
250 MURKIN JM, MARTZKE JS, BUCHAN AM, et al. A randomized study of the iunfluence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. I Mortality and cardiovascular morbidity. J Cardiothorac Vasc Surg 1995; 110:340-48
251 MURKIN JM, MARTZKE JS, BUCHAN AM, et al. A randomized study of the iunfluence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. II Neurologic and cognitive outcomes. J Cardiothorac Vasc Surg 1995; 110:349-55
252 MURKIN JM, MENKIS AH, DOWNEY D, et al. Epiaortic scanning decreases cerebral emboli during aortic canulation and application of partial occlusion clamp. Ann Thorac Surg 1999; 68:1461-7
253 MURPHY DA. Recognition and management of ascending aortic dissection complicating cardiac surgical operations. J Thorac Cardiovasc Surg 1983; 85:247-53
254 MURPHY GS, HESSEL EA, GROOM RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108:1394-417
255 MURRAY MJ, COOK DJ. Noncardiovascular applications of cardiopulmonary bypass. In: GRAVLEE GP, ed. Cardiopulmonary bypass, principles and practice. Philadelphia: Lippincott, Williams & Wilkins, 2000, 704-23
256 MUSTAFA I, ROTH H, HANAFIAH A, et al. Effect of cardiopulmonary bypass on lactate metabolism. Intensive Care Med 2003; 29:1279-85
256a MYBURGH JA, FINFER S, BELLOMO R, et al. Hydroxyethyl starch or saline fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-11
257 MYERS GJ, LEADON RB, MITCHELL LB, et al. Simple modified ultrafiltration. Perfusion 2000; 15:447-52
258 MYTHEN MG, WEBB AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995; 130:423-9
259 NAIDU SS. Novel percutaneous cardiac assist devices. The science of and incications for hemodynamic support. Circulation 2011; 123:533-43
260 Nathoe HM, Van Dijk D, Jansen EWL, et al. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med 2003; 348:394-402
260a NOLAN JP, MYTHEN MG. Hydroxyethyl starch: here today, gone tomorrow. Br J Anaesth 2013; 111:321-4
261 NOLLERT G, SHINOKA T, JONAS RA. Near-infrared spectrophotometry of the brain in cardiovascular surgery. J Thorac Cardiovasc Surg 1998; 46:167-75
262 NOMOTO S, SHIMAHARA Y, KUMADA K, et al. Influence of hepatic mitochondrial redox state on complement biosynthesis and activation duriung and after cardiopulmonary bypass operations. Eur J Cardiothorac Surg 1996; 10:273-8
263 NOVITZKY D, FONTANET H, SNYDER M, et al. Impact of tri-iodo-thyronine on the survival of high-risk patients undergoing heart surgery. Cardiology 1996; 87:509-15
264 NUSSMEIER NA, CHENG W, MARINO M, et al. Temperature during cardiopulmonary bypass: The discrepancies between monitoring sites. Anesth Analg 2006; 103:1373-9
265 O’HARA JF. Low-dose «renal» dopamine. Anesthesiol Clin N Am 2000; 18:835-51
266 OHATA T, SAWA Y, KADOBA K, et al. Effect of cardiopulmonary bypass under tepid temperature on inflammatory reactions. Ann Thorac Surg 1997; 64:124-8
267 OHRI SK, BOWLES CW, MATHIE RT, et al. Effect of cardiopulmonary bypass perfusion protocols on gut tissue oxygenation and blood flow. Ann Thorac Surg 1997; 64:163-8
268 OKUTANI R, PHILBIN D, ROSOW C. Effect of hypothermic hemodilutional cardiopulmonary bypass on plasma sufentanil and catecholamine concentrations in humans. Anesth Analg 1988; 67:667-73
269 ONO M, JOSHI B, BRADY K, et al. Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke. Br J Anaesth 2012; 109:391-8
270 OPAL SM. The host response to endotoxin, antipolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 2007; 297:365-77
271 PAGEL PS. Levosimendan in cardiac surgery: A unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application ? Anesth Analg 2007; 104:759-61
272 PANNEN BH. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 2002; 94:1448-57
273 PAQUET C, DESCHAMPS A, DENAULT AY, et al. Baseline regional cerebral oxygen saturation correlates with left ventricular systolic and diastolic function. J Cardiothorac Vasc Anesth 2008; 22:840-6
274 PAROLARI A, ALAMANNI F, GHERLI T, et al. Cardiopulmonary bypass and oxygen consumption : oxygen delivery and hemodynamics. Ann Thorac Surg 1999; 67:1320-7
275 PATEL BM, CHITTOK DR, RUSSEL JA, WALLEY KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-82
276 PATEL PA, DESAI ND. Con: Cardiac surgery should be performed under warm conditions. J Cardiothorac Vasc Surg 2012; 26:949-51
277 PATEL RL, TURTLE MR, CHAMBERS DJ, et al. Alpha-stat acid-base regulation during cardiopulmonary bypass improves neuropsychologic outcomes in patients udergoing coronary artery bypass grapfting. J Thorac Cardiovasc Surg 1996; 111:1267-79
277a PERNER A, HASSE N, GUTTORMSEN AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012; 367:124-34
278 PETERSON C, FOX JA, DEVALLIS P, et al. Starvation in the midst of cardiopulmonary bypass: diabetic ketoacidosis during cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:910-6
279 PEVNI D, FROLKIS I, IAINA A, et al. Protamine cardiotoxicity and nitric oxide. Eur J Cardiothorac Surg 2001; 20:147-52
280 PHILIPPOU H, ADAMI A, DAVIDSON SJ, et al. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during CPB. Thromb Haemost 2000; 84:124-8
281 PREISMAN S, KEIDAN I, PEREL A, et al. Anesthesia for port-access cardiac surgery in a pediatric population. J Cardiothorac Vasc Anesth 2005; 19:526-9
282 PULIDO JN, PARK SJ, RIHAL CS. Percutaneous left ventricular assist devices: Clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth 2010; 24:478-86
283 Puskas JD, Williams WH, Duke PG, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: A prospective randomized comparison of two-hundred unselected patients undergoing off-pump versus conventional coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003; 125:797-808
284 Raja SG, Dreyfus GD. Off-pump coronary artery bypass surgery: To do or not to do? Current best available evidence. J Cardiothorac Vasc Anesth 2004; 18:486-505
285 RAMPIL IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998: 89:980-1002
286 RANUCCI M, CAZZANIGA A, SORO G, et al. The anti-thrombin III saving effect of reduced systemic heparinization and heparin-coated circuits. J Cardiothorac Vasc Anesth 2002; 16:316-20
287 RANUCCI M, DE BENEDETTI D, BIANCHINI C, et al. Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomised, double-blind, placebo-controlled study. Minerva Anesthesiol 2010; 76:249-59
288 RANUCCI M, ROMITTI F, ISGRO G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary opertaions. Ann Thorac Surg 2005; 80:2213-20
289 REBEYKA I. Hypothermia. In: JONAS RA, ELLIOTT MJ. Cardiopulmonary bypass in neonates, infants and young children. Oxford: Butterworth, 1994, 54-66
290 REES K, BERANEK-STANLEY M, BURKE M, et al. Hypothermia to reduce neurological damage following coronary artery bypass surgery. Cochrane Database Syst Rev 2001; CD002138
291 REEVES ST, GLAS KE, ELTZSCHIG H, et al. Guidelines for performing a comprehensive epicardial echocardiographic examination: Recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2007; 20:427-37
292 RENTON KW, NICHOLSON TE. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. J Pharmacol Exp Ther 2000; 294:524-30
293 RIDDINGTON DW, VENKATESH B, BOIVIN CM, et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 1996; 275:1007-12
294 RINDER C. Cellular inflammatory response and clinical outcome in cardiac surgery. Curr Opin Anaesthesiol 2006; 19:65-8
295 RINGELSTEIN EB, DROSTE DW, BABIKIAN VL, et al. Consensus on microembolus detection by TCD. Stroke 1998; 29:725-9
296 RINNE TT. Cardioprotection and cardioplegia. In: THYS DM, et al, eds. Textbook of cardiothoracic anesthesiology. New York, McGraw-Hill Co, 2001, 488-511
297 RIOU B, ADNET F, BAUD F, et al. Recommandations sur les indications de l’assistance circulatoire dans le traitement des arrêts cardiaques réfractaires. Ann Fr Anesth Réanim 2009; 28:182-6
298 ROACH GW, KANCHUGER M, MORA MANGANO C, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996; 335:1857-64
299 RODRIGUEZ RA, EDMONDS HL, AUDEN SM, et al. Auditory brainstem-evoked responses and temperature monitoring during pediatric cardiopulmonary bypass. Can J Anaesth 1999; 46:832-9
300 ROMAN PEF, GRIGORE AM. Pro: hypothermic cardiopulmonary bypass should be used routinely. J Cardiothorac Vasc Surg 2012; 26:945-8
301 ROSEN D, ROSEN K. Elimination of drugs and toxins during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11:337-40
302 ROSENKRANZ ER. Myocardial preservation. In: ESTEFANOUS F, et al, Eds. Cardiac anesthesia. principles and clinical practice. Philadelphia, Lippincott Williams & Wilkins, 2001, 387-414
303 ROUGE P, BUYS S. CEC et circulation hépatosplanchnique. In: JANVIER G, LEHOT JJ (ed). Circulation extracorporelle: principes et pratique, 2ème édition. Paris, Arnette Groupe Liaison SA, 2004, pp 363-75
304 ROYSTER RL. Myocrdial Dysfunction following Cardiopulmonary Bypass: Recovery patterns, predictors of initropic needs, theoretical concepts of inotropic administration. J Cardiothor Vasc Anesth 1993; 7 (Suppl 2): 19-25
305 ROYSTON D, TAYLOR KM, BIDSTRUP BP, et al. Effect of aprotinin on need for blood transfusion after repeat open.heart surgery. Lancet 1987; 2:1289-91
306 RUSSEL JA, NAVICKIS RJ, WILKES MM. Albumin versus colloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth 2004: 18:429-37
307 ROZENTAL T, SHORE-LESSERSON L. Pharmacologic management of coagulopathy in cardiac surgery: An update. J Cardiothorac Vasc Anesth 2012; 26:660-79
308 SAGAR UN, KANDULA P. N-acetylcysteine in cardiovascular surgery-associated renal failure: A meta-analysis. Ann Thorac Surg 2009; 87:139-47
309 SALAZAR JD, WITYK RJ, GREGA MA, et al. Stroke after cardiac surgery: short- and long-term outcomes. Ann Thorac Surg 2001; 72:1195-201
310 SANO T, DRUMMOND J, PATEL P, et al. A comparison of the cerebral protective effects of isoflurane and mild hypothermia in a model of incomplete forebrain ischemia in the rat. Anesthesiology 1992; 76:221-8
311 SCALIA GM, McCARTHY PM, SAVAGE RM, et al. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr 2000; 13:754-63
312 SCHMITZ C, WEINREICH S, WHITE J, et al. Can particulate extraction from the ascending aorta reduce neurologic injury in cardiac surgery ? J Thorac Cardiovasc Surg 2003; 126:1829-38
313 SCHNEIDER B, ZIENKIEWICZ T, JANSEN V, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol 1996; 77:1202-9
314 SCHOENWALD PK. Intraoperative management of renal function in the surgical patient at risk. Anesthesiol Clin N Am 2000; 18:719-37
315 SCHWARTZ G, LITSCHER G. Transcranila cerebral oxymetry, transcranial Doppler sonography, and heart rate variability: useful neuromotitoring tools in anaesthesia and intensive care ? Eur J Anaesthesiol 2002; 19:543-9
316 SCHWARZ B, MAIR P, MARGREITER J, et al. Experience sith percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med 2003; 31:758-64
317 SCHWINN DA, LEONE BJ, SPAHN DR, et al. Desensitiation of myocardial b-adrenergic receptors during cardiopulmonary bypass. Circulation 1991; 84:2559-67
318 SEARLES B, DARLING E. Ultrafiltration in cardiac surhery. In: MONGERO LB, BECK JR (eds). On bypass. Advanced perfusion techniques. Totowa (NJ, USA): Humana Press 2010, 193-210
319 SEBEL PS, LANG E, RAMPIL IJ, et al. A multicenter study of bispectral electroencephylogram analysis for monitoring anesthetic depth. Anesth Analg 1997; 84:891-9
320 SEDRAKYAN A, TREASURE T, ELEFTERIADES JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004; 128:442-8
321 SETTERGREN G, ÖHQVIST G. Renal dysfunction during cardiac surgery. Curr Opin Anaesthesiol 1994; 7:59-64
322 SHAABAN T, HARMER M, LATTO P. Jugular bulb oximetry during cardiac surgery. Anaesthesia 2001; 56:24-37
323 SHANN KG, LIKOSKY DS, MURKIN JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006; 132:283-90
324 Sharony R, Bizekis CS, Kanchuger M, et al. Off-pump coronary artery bypass grafting reduces mortality and stroke in patients with atheromatous aortas: A case control study. Circulation 2003; 108 (suppl II):15-20
325 SHERWOOD ER, TOLIVER-KINSKY T. Mechanisms of the inflammatory response. Best Pract Res Clin Anaesthesiol 2004; 18:385-405
326 SHI Y, DENAULT AY, COUTURE P, et al. Biventricular filling patterns after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006; 131:1080-6
326a SHIM JK, YANG SY, YOO YC, et al. Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery. Br J Anaesth 2013; 110:47-53
327 SHROYER AL, COOMBS LP, PETERSON ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75:1856-64
328 SILVFAST T, PETTILÄ V. Outcome from severe accidental hypothermia in Southern Finland - A 10-year experience. Resuscitation 2003; 59:285-90
329 SIMMONS PI, ANDERSON RJ. Increased serum creatinine: A marker for adverse outcome before and after cardiac surgery. Crit care Med 2002; 30:1664-5
330 SINCLAIR DG, HASLAM PL, QUINLAN GJ, et al. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest 1995; 108:718-24
331 SLATER JP, GUARINO T, STACK J, et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg 2009; 87:36-44
332 SLAUGHTER MS, ROGERS JG, MILANO CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-51
333 SLINGER P. Perioperative lung injury. Best Pract Res Clin Anaesthesiol 2008; 22: 177-91
334 SMILEY RM, VUILLEMOZ Y. Cardiac surgery causes desensitization of the b-adrenergic system of immune lymphocytes. Anesth Analg 1992; 74:212-8
335 SNIECINSKI RM, CHANDLER WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113:1319-33
336 SNIECINSKI RM, LEVY JH. The inflammatory response to cardiopulmnary bypass. In: MONGERO LB, BECK JR (eds). On bypass. Advanced perfusion techniques. Totowa (NJ, USA): Humana Press 2010, 125-140
337 SPAHN DR, DETTORI N, KOCIAN R, CHASSOT PG. Transfusion in the cardiac patient. Crit Care Clin 2004; 20:269-79
338 STAHL GL, SHERMAN SK, SMITH PK, LEVY JH. Complement activation and cardiac surgery : a novel target for improving outcomes. Anesth Analg 2012 ; 115 :759-71
339 STAMMERS AH. Historical aspects of cardiopulmonary bypass: From antiquity to acceptance. J Cardiothorac Vasc Anesth 1997; 11:266-74
340 STERN R, WEISS C, STEINBACH J, et al. Isoflurane uptake and elimination are delayed by absorption of anesthetic by the Scimed membrane oxygenator. Anesth Analg 1989; 69:657-62
341 STUMP DA, JONES TJJ, RORIE KD. Neurophysiologic monitoring and outcomes in cardiovascular surgery. J Cardiothorac Vasc Anesth 1999; 13:600-13
342 SUNGURTEKIN H, BOSTON US, COOK DJ. Bypass flow, mean arterial pressure, and cerebral perfusion during cardiopulmonary bypass in dogs. J Cardiothorac Vasc Anesth 2000; 14:25-8
343 SUNGURTEKIN H, COOK DJ, ORSZULAK TA, et al. Cerebral response to hemodilution during hypothermic cardiopulmonary bypass in adults. Anesth Analg 1999; 89:1078-83
344 SUNGURTEKIN H, PLÖCHL W, COOK DJ. Relationship between cardiopulmonary bypass flow rate and cerebral embolization in dogs. Anesthesiology 1999; 91:1387-93
345 SVENMARKER S, HAGGMARK S, JANSSON E, et al. Use of heprin-bonded circuits in cardiopulmonary bypass improves clinical outcome. Scand Cardiovasc J 2002; 36:241-6
346 SVENNEVIG JL, LINDBERG H, GEIRAN O, et al. Should the lungs be ventilated during cardiopulmonary bypass ? Clinical, hemodynamic, and metabolic changes in patients undergoing elective coronary artery surgery. Ann Thorac Surg 1984; 37:295
347 SVYATETS M, TOLANI K, ZHANG M, et al. Perioperative management of deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 2010; 24:644-55
348 SWAMINATHAN M, PHILIPS-BUTE BG, CONLON PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76:784-91
349 SWAMINATHAN M, STAFFORD-SMITH M. Renal dysfunction after vascular surgery. Curr Opin Anaesthesiol 2003; 16:45-52
350 SYLVIRIS S, CALAFIORE P, MATALANIS G, et al. The intraoperative assessment of ascending aortic atheroma: epiaortic imaging is superior to both transesophageal echocardiography and direct palpation. J Cardiothorac Vasc Anesth 1997; 11:704-10
351 TAEGER K, WENINGER E, SCHMELZER F, et al. Pulmonary kinetics of fentanyl and alfentanil in surgical patients. Br J Anaesth 1988; 61:425-34
352 TAILEFER MC, DENAULT Y. Cerebral near-infrared spectroscopy in adult heart surgery: systematic review of its clinical efficacy. Can J Anesth 2005; 52:79-87
353 TALLMAN RD. Acid-base regulation, alpha-stat, and the Emperor’s new clothes. J Cardiothorac Vasc Anesth 1997; 11:282-8
354 te Velthuis H, Jansen PG, Oudemans-van Straaten HM, et al. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg 1995; 110: 1663-9
355 THADHANI R, PASCUAL M, BONVENTRE JV. Acute renal failure. N engl J Med 1996; 334:1448-60
356 TINGLEFF J, JOYCE FS, PETTERSON G. Intraoperative echocardiography study of air embolism during cardiac operations . Ann Thorac Surg 1995; 60:673-7
357 TIREN C, ANDERSON RE, BARR G, et al. Clinical comparison of three different anaesthetic depth monitors during cardiopulmonary bypass. Anaesthesia 2005; 60:189-93
358 TUMAN KJ, McCARTHY RJ, NAJAFI RJ, IVANKOVICH AD. Differential effects of advanced age on neurologic and cardiac risks of coronary operations. J Thorac Cardiovasc Surg 1999; 104:1510-7
359 TUMLIN JA, FINKEL KW, MURRAY PT, et al. Fenoldopam mesylate in early acute tubular necrosis : a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005 ; 46 :26-34
360 UMSHEID CA, KOHL BA, WILLIAMS K. Antifibrinolytic use in adult cardiac surgery. Curr Opin Hematol 2007; 14:455-67
361 UNTCH BR, JESKE WP, SCHWARTZ J, et al. Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass grafting. Clin Appl Thromb Hemost 2008; 14-141-8
362 URZUA J, TRONCOSCO S, BUGEDO G, et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anaesth 1992; 6:309-12
363 Van Dijk D, Jansen EW, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 2002; 287: 1405-12
364 VAN DIJK D, SPOOR M, HIJMAN R, et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA 2007; 297:701-8
365 VAN WERMESKERKEN GK, LARDENOYE JWH, HILL SE, et al. Intraoperative physiologic variables and outcome in cardiac surgery. Part II. Neurologic outcome. Ann Thorac Surg 2000; 69:1077-83
366 VAN WEZEL HB, DEJONG SWM. Clinical use of glucose-insulin-potassium in cardiac surgery and acute myocardial infarction: an overview. Semin Cardiothorac Vasc Anesth 2003; 7:77-83
367 VISTARINI N, AIELLO M; MATTIUCCI G, et al. Port-access minimally invasive surgery for atrial septal defects: a 10-year single-center experience in 166 patients. J Thorac Cardiovasc Surg 2010; 139:139-45
368 VITEZ TS. Pro: Calcium salts are contraindicated in the weaning of patients from cardiopulmonary bypass J Cardiothor Vasc Anesth 1988; 2:567-70
369 VRETENAR DF, URSCHEL JD, PARROTT JC, UNRUH HW. Cardiopulmonary bypass resuscitation for accidental hypothermia. Ann Thorac Surg 1994; 58:895-8
370 VROOM MB. Epidemiology and pharmacotherapy of acute heart failure. Semin Cardiothorac Vasc Anesth 2003; 7:3-12
371 WALKE CM, CLEMENTS F, GLOWER DD, et al. False-positive diagnosis of aortic dissection associated with femoral cardiopulmonary bypass. Anesthesiology 1998; 88:1119-21
372 WALL MH, ROYSTER RL. Pulmonary dysfunction after cardiopulmonary bypass: should we ventilate the lungs on pump ? Crit Care Med 2000; 28:1658-60
373 WALPOTH BH, WALPOTH-ASLAN BN, MATTLE HP, FISCHER A, VON SEGESSER L, et al. Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming. N Engl J Med 1997; 337:1500-5
374 WANG G, BAINBRIDGE D, MARTIN J, et al. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109:320-30
375 WARREN OJ, SMITH AJ, ALEXIOU C, et al. The inflammatory response to cardiopulmonary bypass: Part 1 – Mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23: 223-31
376 WARREN OJ, WATRET AL, DE WIT KL, et al. The inflammatory response to cardiopulmonary bypass: Part 2 – Anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth 2009; 23: 384-93
377 WATANABE T, HRITA H, KOBAYASHI M, et al. Brain tissue pH, oxygen tension and carbon dioxide tension in profoundly hypothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 97:396-401
378 WEITZ JI, HIRSH J. New anticoagulant drugs. Chest 2001; 119:95s-107s
379 WELSBY IJ, RYAN JM, BOOTH JV, et al. The bispectral index in the diagnosis of perioperative stroke: A case report and discussion. Anesth Analg 2003; 96:435-7
380 WHITLOCK RP, CHAN S, DEVEREAUX PI, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass : A meta-analysis of randomized trials. Eur Heart J 2008 ; 29 : 2592-600
381 WILLIAMS MR, D’AMBRA AB, BECK JR, et al. A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg 2000; 70:873-7
382 WITHINGTON D, MENARD G, HARRIS J, et al. Vecuronium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children. Can J Anaesth 2000; 47:1188-95
383 WOLBERG AS, MENG ZH, MONROE DM, et al. A systematic evaluation of temperature on coagulation enzyme activity ands platelet function. J Trauma 2004; 56:1221-8
384 WONG KC. Physiology and pharmacology of hypothermia. West J Med 1983; 138:227-32
385 WOODS KL, FLETCHER S. Long-term outcome after intravenous magnesium sulfate in suspected acute myocardial infarction: The second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994; 343:816-9
386 YAO FSF, TSENG CCA, HO CYA, et al. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18:553-8
387 YAU TM, CARSON S, WEISEL RD, et al. The effect of warm heart surgery on postoperative bleeding. J Thorac Cardiovasc Surg 1992; 103:1155-63
388 Zangrillo A, Crescenzi G, Landoni G, et al. Off-pump coronary artery bypass grafting reduces postoperative neurologic complications. J Cardiothorac Vasc Anesth 2005; 19:193-6
389 ZANGRILLO A, GAROZZO FA, BIONDI-ZOCCAI G, et al. Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac surgery: a meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg 2010; 139:1162-9